Eli Lilly & Co. vs Johnson & Johnson
LLY vs JNJ — side-by-side comparison from reported financials. LLY leads 6, JNJ leads 5 of 11 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | LLY | JNJ |
|---|---|---|
| Price | $1 177.20 | $261.79 |
| Market cap | $1.05T | $631B |
| Revenue (TTM) | $79.7B | $97.9B |
| Revenue growth | +31.7% | +5.6% |
| Net margin | 33.5% | 21.5% |
| Free cash flow | $18.2B | $22.2B |
| Net cash (debt) | ($35.2B) | ($27.8B) |
| 1-year price return | +37.6% | +37.0% |
| P/E | 41.6 | 29.9 |
| P/E vs own history (cheap-side %) | 88% | 16% |
| Dividend yield | 0.52% | 2.00% |
| Return on equity | 93% | 26% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 50,000 | 140,800 |
Full résumé-style profiles: LLY CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.